WA-SPIE
The Awards Committee of SPIE, the international society for optics and photonics, today announced the recipients of its prestigious annual awards. Honoring transformative advancements in a variety of professional areas — including medicine, astronomy, lithography, optical metrology, optical design, and community leadership — the Society's awards recognize technical accomplishments as well as committed service to SPIE and support of its organizational mission.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240110537408/en/
Akhlesh Lakhtakia, the 2024 recipient of the SPIE Gold Medal. (Photo: Business Wire)
SPIE Gold Medal: Akhlesh Lakhtakia
For pioneering research on electromagnetic fields in complex materials including isotropic chiral, bianisotropic, and composite materials, metamaterials, and nanomaterials.
SPIE President's Award: Katie Schwertz
For outstanding service to SPIE and the optics community, through work that advances optical systems design, engages students, and shares the excitement of optics with the public.
SPIE Directors' Award: Halina Rubinsztein-Dunlop
For pioneering research in optics and photonics, and for distinguished service to SPIE as a leading light in promoting educational programs and supporting women in science.
SPIE Mozi Award: Andrea Alù
For seminal contributions to the field of optical metamaterials as well as their applications for wavefront manipulation and enhancement of nonreciprocal and nonlinear phenomena.
SPIE Mozi Award: Teri W. Odom
For significant contributions to the field of nanophotonics and to the development of moiré photonics.
SPIE Britton Chance Award in Biomedical Optics: Gerard L. Coté
For transformative advances in both fundamental and translational optical research toward the diagnosis and monitoring of chronic and infectious diseases.
SPIE Biophotonics Technology Innovator Award: Ji-Xin Cheng
For the invention and commercialization of mid-infrared photothermal microscopy that allows highly sensitive dye-free bond-selective imaging of living cells and organisms.
SPIE Rudolf and Hilda Kingslake Award in Optical Design: David Shafer
For outstanding contributions to the field of optical design including DUV and EUV photolithographic scanner designs that define the current technological limit of the semiconductor industry.
SPIE Harrison H. Barrett Award in Medical Imaging: Kyle J. Myers
For fundamental contributions to the field of image science, with an emphasis on the role of science in regulatory evaluations of imaging methods.
SPIE Harold E. Edgerton Award in High-Speed Optics: Clara Saraceno
For groundbreaking contributions to the development of ultrafast high-power lasers and laser-driven THz sources.
SPIE Dennis Gabor Award in Diffractive Optics: Jürgen Czarske
For significant contributions to the development of digital holography, and related techniques for biomedicine, fiber communication, imaging, information processing, and laser metrology.
SPIE A.E. Conrady Award in Optical Engineering: Thomas U. Kampe
For industry-recognized leadership in optical engineering, design, and development – including critical Earth-monitoring instruments – as well as for mentoring the next generation of optical engineers.
SPIE G. G. Stokes Award in Optical Polarization: Curtis R. Menyuk
For pioneering studies of linear and nonlinear polarization effects in guided-wave photonics which have impacted basic science, telecommunications systems, lasers, and many other photonics-based technologies.
SPIE Chandra S. Vikram Award in Optical Metrology: Anand Asundi
For numerous contributions to coherent optical metrology and sensing, with special attention to digital technologies.
SPIE Frits Zernike Award for Microlithography: Richard Sandstrom
For leadership in the development of lithographic-grade lasers and EUV light sources.
SPIE Diversity Outreach Award: Preeti Jagadev
For excellence in promoting and advocating diversity, equity, and inclusion in STEM.
SPIE Maria Goeppert Mayer Award in Photonics: Iam-Choon Khoo
For foundational contributions to linear and nonlinear optical properties of liquid crystals and their applications in wide-ranging, wave-mixing, and self-action effects.
SPIE Maiman Laser Award: Anne L’Huillier
For the discovery of high harmonic generation in gases, and contributions to developments in attoscience.
SPIE María J. Yzuel Educator Award: Mary G. Turner
For a lifetime of dedication to the teaching of optical design, and for services to the optics community.
SPIE Aden and Marjorie Meinel Technology Achievement Award: M. Saif Islam
For highly impactful innovations in ultra-fast and highly efficient photodetectors enabled by photon-trapping structures.
The complete listing of the SPIE Society Awards and recipients is available here.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $24 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240110537408/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom